www.fdanews.com/articles/138979-gsk-partner-nps-amend-pact-to-add-stem-cell-research-two-compounds

GSK, Partner NPS Amend Pact to Add Stem Cell Research, Two Compounds

August 4, 2011

GlaxoSmithKline will be able to take an osteoporosis compound in a new direction for possible use in stem cell transplants under a new deal with drug partner NPS Pharmaceuticals.
MedCity News